Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000010

Chief Commercial Officer gave up 590 shares (to pay taxes)

  • Chief Commercial Officer acquired 1,738 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Poddar Richa · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-14 Exercise or conversion : show line 1 in the form +1,738 3,231 D
2022-02-14 Shares withheld for taxes : show line 2 in the form −590 $30.50 $17,995 2,641 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-14 Exercise or conversion : show line 3 in the form Restricted stock units −1,738 1,738 D
Loading xslF345X03/wf-form4_164504883633702.xml…